Navigation Links
Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01

ProductsUltrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
Company ALPCO Diagnostics
Item Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
Features 
Description Qualitative and quantitative evaluation of pancreatic -cell function is not only of use in the pre- and post-diagnostic study of the natural history of diabetes mellitus, but is also relevant in clinical practice as a guide to the correct choice of treatment. Peripheral insulin levels cannot be used to assess -cell function because of the large and variable uptake from the portal circulation into the liver, and because insulin assays cannot distinguish endogenous from exogenous insulin1,3. Human C-peptide is a 31 amino acid chain with a molecular mass of approximately 3020 daltons. Within the pancreatic -cell, proinsulin is cleaved into one molecule of C-peptide and one molecule of insulin. C-peptide is subsequently released into the circulation at concentrations equimolar to those of insulin. In contrast to insulin, C-peptide is only minimally extracted by the liver. Peripheral C-peptide concentrations therefore reflect the secretion of -cells more accurately than insulin2,4 The ALPCO C-peptide ELISA is a solid phase two-site enzyme immunoassay. It is based on the direct sandwich technique in which two monoclonal antibodies are directed against separate antigenic determinants on the C-peptide molecule. During incubation, C-peptide in the sample reacts with peroxidase-conjugated anti-C-peptide antibodies and anti-C-peptide antibodies bound to microplate wells. A simple washing step removes unbound enzyme labeled antibody. The bound conjugate is detected by reaction with 3,3',5,5'-tetramethylbenzidine (TMB). The reaction is stopped by adding acid. The colorimetric endpoint is read spectrophotometrically.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01
2. Ultrasensitive TSH EIA Thyroid Function 025-BC-1003
3. Hepatitis B Virus DNA Ultrasensitive Quantitative Real-Time PCR
4. HIV-1 Quantitative PCR with Reflex to HIV-1 Ultrasensitive Quantitative PCR
5. HIV-1 Ultrasensitive Quantitation by PCR
6. Human Immunodeficiency Virus 1 RNA Quantitative PCR with Reflex to Ultrasensitive RNA Quantitative PCR
7. Human Immunodeficiency Virus 1 Ultrasensitive RNA Quantitative PCR
8. Human Immunodeficiency Virus 1 Ultrasensitive Quantitative PCR with Reflex to HIV Quantitative PCR
9. Prostate Specific Antigen, Ultrasensitive
10. Thyroid Stimulating Hormone Ultrasensitive
11. C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products:
(Date:6/29/2015)... La Mirada, CA (PRWEB) , ... June 29, ... ... organizations, has announced that Dr. Gabriel Martin Del Campo is their newest FAA-certified ... Administration (FAA) physical examination is available for all fledging pilots seeking to obtain ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Society for Immunotherapy ... (EMA) has granted accelerated approval of Bristol-Myers Squibb’s Opdivo® (nivolumab) for the treatment ... the approval of nivolumab for patients with metastatic melanoma in Europe represents a ...
(Date:6/29/2015)... ... ... Displays and Exhibits , a top online retailer of trade ... that include branding. Enter price code brand2015 for a ten percent discount on all ... promotional materials, all should integrate the company logo to communicate the brand. What is ...
(Date:6/29/2015)... ... 29, 2015 , ... Brittenford Systems, a provider of financial ... businesses across the United States, has announced that it has been named to ... year. , Based on company revenue and number of employees, Bob Scott’s Top ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors and Usability ... 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors , ... engineering to the design of new products as well as to postmarket surveillance ...
Breaking Medicine News(10 mins):Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3
... created much panic and confusion among the villagers who continue ... would answer their prayers. // Some people even feel that ... 'khasra' by local community members. ,Around 120 children ... measles, and exhibit clear symptoms of the disease - fever, ...
... Birth under the Guangdong Family Planning Research Institute in ... discovered 39 cases of new abnormal chromosomes. // ... scientists for genetic and cloning researches. ,Director ... these cases of abnormal chromosomes have been verified by ...
... Medical Center (UCI) for the past decade faced a lot ... liver transplant program. // ,It was not able ... found the program to have marginal staffing and inadequate resources. ... to assure quality and success. It also questioned the UCI's ...
... Prescriptions have the prerogative of choice. They seem to be ... Neurology Neurosurgery and Psychiatry suggests that // Family doctors are ... headache as compared to men of the same age. ... for nearly 20% of sick leave cases. The findings are ...
... private healthcare providers into the public NHS system thereby taking ... //Mr Blair and the health secretary, Patricia Hewitt, welcomed the ... mark the launch of NHS Partners Network. ,The ... 'future success' of the NHS. "Wherever people are treated - ...
... lesser risk of Parkinson’s, according to novel research, published ... ,The research team, as part of their ... healthy people, belonging to the same age and sex. ... light on their personality traits and behavior also including ...
Cached Medicine News:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4